U.S. advisers support Pfizer COVID-19 boosters for younger teens

Brasil Notícia Notícia

U.S. advisers support Pfizer COVID-19 boosters for younger teens
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 PennLive
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

The CDC’s advisers were swayed by real-world U.S. data showing that symptomatic COVID-19 cases and hospitalizations are between seven and 11 times higher in unvaccinated adolescents than vaccinated ones.

If the CDC agrees, about 5 million of the younger teens, those 12 to 15, would be eligible for a booster right away because they got their last shot at least five months ago.

Children tend to suffer less serious illness from COVID-19 than adults. But child hospitalizations are rising during the omicron wave -- the vast majority of them unvaccinated. The chief safety question for adolescents is a rare side effect called myocarditis, a type of heart inflammation seen mostly in younger men and teen boys who get either the Pfizer or Moderna vaccines. The vast majority of cases are mild — far milder than the heart inflammation COVID-19 can cause — and they seem to peak in older teens, those 16 and 17.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

PennLive /  🏆 463. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

COVID-19 scams: How to prevent buying fake COVID testsCOVID-19 scams: How to prevent buying fake COVID testsIf you end up falling victim to a scam, you can report it to the FTC. Find out how.
Consulte Mais informação »

FDA Approves Pfizer COVID-19 Boosters For 12- to 15-Year-OldsFDA Approves Pfizer COVID-19 Boosters For 12- to 15-Year-OldsThe FDA has approved COVID-19 booster for 12- to 15-year-olds as teens return to school amid the omicron surge.
Consulte Mais informação »

CDC recommends 5-month gap for Pfizer COVID-19 booster doseCDC recommends 5-month gap for Pfizer COVID-19 booster doseThe U.S. Centers for Disease Control and Prevention on Tuesday recommended shortening the interval between Pfizer-BioNTech's second COVID-19 vaccine dose and the booster shot to five months from six.
Consulte Mais informação »

Pfizer to supply U.S. with 10 mln more courses of COVID-19 pillsPfizer to supply U.S. with 10 mln more courses of COVID-19 pillsThe Biden administration doubled its order for Pfizer Inc's oral COVID-19 antiviral treatment, the company and the White House said on Tuesday, providing the government a total of 20 million courses as it fights a record surge in COVID-19 cases.
Consulte Mais informação »

Pediatrician answers your questions on Pfizer Covid-19 booster for ages 12-15Pediatrician answers your questions on Pfizer Covid-19 booster for ages 12-15The FDA gave emergency use authorization for booster doses of Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 on Monday. A pediatrician answers parents' questions about the shots.
Consulte Mais informação »



Render Time: 2025-02-26 21:07:40